blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3578183

EP3578183 - RNA INTERFERENCE IN OCULAR INDICATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.07.2022
Database last updated on 26.03.2025
FormerThe patent has been granted
Status updated on  06.08.2021
FormerGrant of patent is intended
Status updated on  28.03.2021
FormerRequest for examination was made
Status updated on  19.02.2021
FormerGrant of patent is intended
Status updated on  25.10.2020
FormerRequest for examination was made
Status updated on  08.11.2019
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 30.10.2024  [2024/44]
Applicant(s)For all designated states
Phio Pharmaceuticals Corp.
257 Simarano Drive, Suite 101
Marlborough, MA 01752 / US
[2019/50]
Inventor(s)01 / Libertine, Lyn
61 Nixon Road
Framingham, MA Massachusetts 01701 / US
02 / Khvorova, Anastasia
10 Rocklawn Road
Westborough, MA Massachusetts 01581 / US
03 / Salomon, William
2 Farrar Avenue, Apt. 2
Worcester, MA Massachusetts 01604 / US
04 / Kamens, Joanne
21 Wessex Road
Newton, MA Massachusetts 02459 / US
05 / Samarsky, Dmitry
15 Wayside Road
Westborough, MA Massachusetts 01581 / US
06 / Woolf, Tod, M.
14 Babe Ruth Drive
Sudbury, MA Massachusetts 01176-1942 / US
07 / Cardia, James
11 Bacon Street
Franklin, MA Massachusetts 02038 / US
 [2019/50]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2019/50]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date19168667.424.03.2011
[2019/50]
Priority number, dateUS201031725410P24.03.2010         Original published format: US 31725410 P
US201031762110P25.03.2010         Original published format: US 31762110 P
[2019/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3578183
Date:11.12.2019
Language:EN
[2019/50]
Type: B1 Patent specification 
No.:EP3578183
Date:08.09.2021
Language:EN
[2021/36]
Search report(s)(Supplementary) European search report - dispatched on:EP27.09.2019
ClassificationIPC:A61K31/713, A61P27/00, A61P27/06, C12N15/113
[2020/43]
CPC:
A61K9/0051 (EP,CN,US); A61K31/713 (EP,CN,US); C12N15/1136 (US);
A61K45/06 (EP,US); A61K47/554 (EP,US); A61K9/0048 (US);
A61P27/00 (EP); A61P27/02 (EP,US); A61P27/06 (EP);
A61P7/10 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07H21/02 (CN); C12N2310/14 (US); C12N2310/313 (US);
C12N2310/321 (US); C12N2310/322 (US); C12N2310/3515 (US);
C12N2320/31 (US); C12N2320/32 (US) (-)
C-Set:
A61K31/713, A61K2300/00 (EP,US)
Former IPC [2019/50]A61K31/713, A61P27/00, A61P27/06, A61P9/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/50]
TitleGerman:RNA-INTERFERENZ BEI AUGENERKRANKUNGEN[2019/50]
English:RNA INTERFERENCE IN OCULAR INDICATIONS[2019/50]
French:INTERFÉRENCE D'ARN DANS DES INDICATIONS OCULAIRES[2019/50]
Examination procedure12.04.2019Examination requested  [2019/50]
09.06.2020Amendment by applicant (claims and/or description)
26.10.2020Communication of intention to grant the patent
17.02.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.03.2021Communication of intention to grant the patent
29.07.2021Fee for grant paid
29.07.2021Fee for publishing/printing paid
29.07.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP11760245.8  / EP2550001
Opposition(s)09.06.2022No opposition filed within time limit [2022/33]
Fees paidRenewal fee
12.04.2019Renewal fee patent year 03
12.04.2019Renewal fee patent year 04
12.04.2019Renewal fee patent year 05
12.04.2019Renewal fee patent year 06
12.04.2019Renewal fee patent year 07
12.04.2019Renewal fee patent year 08
12.04.2019Renewal fee patent year 09
27.03.2020Renewal fee patent year 10
29.03.2021Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.03.2011
AL08.09.2021
AT08.09.2021
CY08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
IT08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
MK08.09.2021
MT08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE24.03.2022
LU24.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
[2024/44]
Former [2024/25]HU24.03.2011
AL08.09.2021
AT08.09.2021
CY08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
IT08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
MK08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE24.03.2022
LU24.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2024/23]AL08.09.2021
AT08.09.2021
CY08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
IT08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
MK08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE24.03.2022
LU24.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2024/20]AL08.09.2021
AT08.09.2021
CY08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
IT08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE24.03.2022
LU24.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/10]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
IT08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE24.03.2022
LU24.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/09]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE24.03.2022
LU24.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/08]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE24.03.2022
LU24.03.2022
Former [2022/47]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/36]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/29]AL08.09.2021
AT08.09.2021
CZ08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/25]AT08.09.2021
CZ08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/24]AT08.09.2021
CZ08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/23]AT08.09.2021
CZ08.09.2021
EE08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
PL08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
PT10.01.2022
Former [2022/21]AT08.09.2021
ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
RS08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
Former [2022/10]ES08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
RS08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
Former [2022/09]ES08.09.2021
FI08.09.2021
LT08.09.2021
RS08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
Former [2022/08]ES08.09.2021
FI08.09.2021
LT08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
Former [2022/07]LT08.09.2021
NO08.12.2021
Documents cited:Search[A]US2008107694  (TROGDEN JOHN T [US], et al) [A] 1-11,15 * the whole document *;
 [A]WO2009102427  (RXI PHARMACEUTICALS CORP [US], et al) [A] 1-11,15* the whole document *;
 [A]WO2010006973  (HOFFMANN LA ROCHE [CH], et al) [A] 1-11,15 * the whole document *
by applicantUS61310611
 WO2007
 US4201860
 US4235871
 US4501728
 US4737323
 US4810646
 US4837028
 US4853386
 US4897355
 WO9014074
 US4992540
 US5013830
 US5028703
 US5032401
 WO9116024
 WO9117424
 US5082936
 WO9203464
 WO9203568
 US5214135
 US5264423
 US5276019
 US5322841
 US5401727
 US5414077
 US5419966
 WO9523162
 US5504079
 US5512667
 US5525719
 US5580972
 US5587469
 US5591843
 US5607677
 US5646126
 US5652359
 WO9813526
 US5736392
 US5767099
 US5777153
 US5780053
 US5789416
 US5830653
 US5830430
 US5849902
 US5851548
 US5855910
 US5968811
 US6020483
 US6242594
 US6331313
 WO0212348
 US6355787
 US6432963
 US6444448
 US6476003
 US2003157030
 US2003216346
 US2004014715
 US2004063654
 US2004072785
 WO2004065601
 US2004162235
 US2005026286
 US2005037496
 US2005042227
 US2005064595
 US2005107325
 US2005265957
 US2005281781
 US2006008910
 WO2006007372
 US7041824
 US2006178327
 US2006240093
 US7205297
 US2007231392
 US2008038296
 WO2008021157
 WO2008036825
 US2008107694
 AU2004206255B
 US2008112916
 US2008152661
 WO2009021157
 WO2009102427
 WO2009126933
 WO2009134487
 US2010010082
 US2010040656
 WO2010033247
    - ZUKER, M., Nucleic Acids Res., (20030000), vol. 31, no. 13, pages 3406 - 15
    - MATHEWS, D. H.; SABINA, J.; ZUKER, M.; TURNER, D. H., J. Mol. Biol., (19990000), vol. 288, pages 911 - 940
    - MATHEWS, D. H.; DISNEY, M. D.; CHILDS, J. L.; SCHROEDER, S. J.; ZUKER, M.; TURNER, D. H., Proc. Natl. Acad. Sci., (20040000), vol. 101, pages 7287 - 7292
    - DUAN, S.; MATHEWS, D. H.; TURNER, D. H., Biochemistry, (20060000), vol. 45, pages 9819 - 9832
    - WUCHTY, S.; FONTANA, W.; HOFACKER, I. L.; SCHUSTER, P., Biopolymers, (19990000), vol. 49, pages 145 - 165
    - AUGUSTYNS, K. et al., Nucl. Acids. Res., (19920000), vol. 18, page 4711
    - Handbook of Chemistry and Physics
    - ORTIAGAO et al., Antisense Res. Dev., (19920000), vol. 2, page 129
    - BJERGARDE et al., Nucleic Acids Res., (19910000), vol. 19, page 5843
    - CARUTHERS et al., Nucleotides, (19910000), vol. 10, page 47
    - Antisense & Nucl. Acid Drug Dev., (19960000), vol. 6, page 267
    - Biochemica Biophysica Acta, (19990000), vol. 1489, page 141
    - Antisense & Nucl. Acid Drug Dev., (19970000), vol. 7, page 63
    - Antisense & Nucl. Acid Drug Dev., (19970000), vol. 7, page 151
    - Antisense & Nucl. Acid Drug Dev., (19970000), vol. 7, page 291
    - Antisense & Nucl. Acid Drug Dev., (19970000), vol. 7, page 187
    - STEC et al., J. Am. Chem. Soc., (19840000), vol. 106, page 6077
    - STEC et al., J. Org. Chem., (19850000), vol. 50, page 3908
    - STEC et al., J. Chromatog., (19850000), vol. 326, page 263
    - LAPLANCHE et al., Nucl. Acid. Res., (19860000), vol. 14, page 9081
    - LAMONE, Biochem. Soc. Trans., (19930000), vol. 21, page 1
    - KAWASAKI et al., J. Med. Chem., (19930000), vol. 36, page 831
    - UHLMANN et al., Chemical Reviews, (19900000), vol. 90, pages 543 - 584
    - AGRAWAL, Methods in Molecular Biology, vol. 26, page 1
    - MCNEAL et al., J. Am. Chem. Soc., (19820000), vol. 104, page 976
    - VIARI et al., Biomed. Environ. Mass Spectrom., (19870000), vol. 14, page 83
    - GROTJAHN et al., Nuc. Acid Res., (19820000), vol. 10, page 4671
    - BERGOT; EGAN, J. Chrom., (19920000), vol. 599, page 35
    - DNA Cloning, (19850000), vol. I, II
    - Methods in Enzymology, Academic Press, Inc.
    - BERGAN et al., Nucleic Acids Research, (19930000), vol. 21, page 3567
    - SHI, Y., Trends Genet, (20030119), vol. 9
    - REICHHART J M et al., Genesis, (20020000), vol. 34, no. 1-2, page 1604
    - YU et al., Proc. Natl. Acad Sci. USA, (20020000), vol. 99, page 6047
    - SUI et al., Proc. Natl. Acad Sci. USA, (20020000), vol. 99, page 5515
    - BARTZATT, R. et al., Biotechnol. Appl. Biochem., (19890000), vol. 11, page 133
    - WAGNER E. et al., Proc. Natl. Acad. Sci., (19920000), vol. 88, page 4255
    - SOTO; OSTROFF, "Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery", Bioconjug Chem, (20080000), vol. 19, no. 4, doi:doi:10.1021/bc700329p, pages 840 - 8, XP055011701

DOI:   http://dx.doi.org/10.1021/bc700329p
    - "Oral Macrophage Mediated Gene Delivery System", SOTO; OSTROFF, Nanotech, (20070000), vol. 2, pages 378 - 381
    - LI et al., "Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88-and Syk kinase-dependent pathways", Clinical Immunology, (20070000), vol. 124, no. 2, doi:doi:10.1016/j.clim.2007.05.002, pages 170 - 181, XP022156792

DOI:   http://dx.doi.org/10.1016/j.clim.2007.05.002
    - SOTO; OSTROFF, Bioconjug Chem, (20080000), vol. 19, page 840
    - VLASSOV et al., Biochimica et Biophysica Acta, (19940000), vol. 1197, pages 95 - 108
    - LEWIS et al., Proc. Natl. Acad. Sci. USA, (19960000), vol. 93, page 3176
    - HOPE et al., Molecular Membrane Biology, (19980000), vol. 15, page 1
    - KAMATA et al., Nucl. Acids. Res., (19940000), vol. 22, page 536
    - LEWIS et al., Proc. Natl. Acad. Sci., (19960000), vol. 93, page 3176
    - MURPHY et al., Proc. Natl. Acad. Sci., (19980000), vol. 95, page 1517
    - ZUCKERMANN, R. N. et al., J. Am. Chem. Soc., (19920000), vol. 114, page 10646
    - ZUCKERMANN, R. N. et al., Int. J. Peptide Protein Res., (19920000), vol. 40, page 497
    - HUNAG et al., Chemistry and Biology, (19980000), vol. . 5, page 345
    - HUNAG et al., Chemistry and Biology, (19980900), vol. 5, page 345
    - LEWIS et al., Proc. Natl. Acad. Sci. US.A., (19960000), vol. 93, page 3176
    - POOGA et al., Nature Biotechnology, (19980000), vol. 16, page 857
    - DEROSSI et al., Trends in Cell Biology, (19980000), vol. 8, page 84
    - ELLIOTT; O'HARE, Cell, (19970000), vol. 88, page 223
    - PROCHIANTZ, A., Curr. Opin. Neurobiol., (19960000), vol. 6, page 629
    - DEROSSI et al., Trends Cell Biol., (19980000), vol. 8, page 84
    - TROY et al., J. Neurosci., (19960000), vol. 16, page 253
    - VIVES et al., J. Biol. Chem., (19970000), vol. 272, page 16010
    - PROCHIANTZ, Current Opinion in Neurobiol., (19960000), vol. 6, page 629
    - ALLINQUANT et al., J Cell Biol., (19950000), vol. 128, page 919
    - SMITH et al., Biochem J, (19910000), vol. 276, pages 417 - 2
    - BUNNELL et al., Somatic Cell and Molecular Genetics, (19920000), vol. 18, page 559
    - LIANG et al., Pharmazie, (19990000), vol. 54, pages 559 - 566
    - GINOBBI et al., Anticancer Res., (19970000), vol. 17, page 29
    - CONSTANTINIDES et al., Pharmaceutical Research, (19940000), vol. 11, page 1385
    - HO et al., J. Pharm. Sci., (19960000), vol. 85, pages 138 - 143
    - M. Y. CHIANG et al., J Biol Chem., (19910000), vol. 266, pages 18162 - 71
    - T. FISHER et al., Nucleic Acids Research, (19930000), vol. 21, page 3857
    - CHEN et al., J. Biol. Chem., vol. 271, page 28259
    - GOULD, S. J.; SUBRAMANI, S., Anal. Biochem., (19880000), vol. 7, pages 404 - 408
    - GORMAN C. M.; MOFFAT, L. F.; HOWARD, B. H., Mol. Cell. Biol., (19820000), vol. 2, pages 1044 - 1051
    - SELDEN, R.; BURKE-HOWIE, K.; ROWE, M. E.; GOODMAN, H. M.; MOORE, D. D., Mol. Cell, Biol., (19860000), vol. 6, pages 3173 - 3179
    - ALTSCHUL, Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 2264 - 68
    - ALTSCHUL, Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 5873 - 77
    - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 10
 US20080199661
 WO2009US00852
 WO2009US05247
 WO2009US05251
 WO2009US06211
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.